{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:57:34Z","timestamp":1791212254095,"version":"4.1.0"},"reference-count":3,"publisher":"American Academy of Pediatrics (AAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,1]]},"abstract":"<jats:p>The Advisory Committee on Immunization Practices (ACIP), a group of medical and public health experts that provides advice to the Centers for Disease Control and Prevention, normally meets 3 times per year to develop US vaccine recommendations. The ACIP met October 23 to 24, 2024, to discuss influenza vaccines, chikungunya vaccines, COVID-19 vaccines, RSV (respiratory syncytial virus) immunizations, meningococcal vaccines, human papillomavirus vaccines, pneumococcal vaccines, and adult and child\/adolescent immunization schedule revisions. This update summarizes the proceedings of these meetings, with an emphasis on topics that are most relevant to the pediatric population. Major updates for pediatric clinicians include information regarding COVID-19 and influenza vaccine recommendations, meningococcal vaccination considerations, and updates regarding the implementation and effectiveness of RSV immunization in pregnant people and infants.<\/jats:p>","DOI":"10.1542\/peds.2024-069926","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:02:08Z","timestamp":1737676928000},"source":"Crossref","is-referenced-by-count":4,"title":["October 2024 ACIP Meeting Update: Influenza, COVID-19, RSV, and Other Vaccines"],"prefix":"10.1542","volume":"155","author":[{"given":"Claudia","family":"Gaviria-Agudelo","sequence":"first","affiliation":[{"name":"1Department of Pediatrics, University of South Florida Morsani College of Medicine, Tampa, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra B.","family":"Yonts","sequence":"additional","affiliation":[{"name":"2Department of Pediatrics, Children\u2019s National Hospital, Washington D.C."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Kimberlin","sequence":"additional","affiliation":[{"name":"3Department of Pediatrics, University of Alabama at Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean T.","family":"O\u2019Leary","sequence":"additional","affiliation":[{"name":"4Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant C.","family":"Paulsen","sequence":"additional","affiliation":[{"name":"5Department of Pediatrics, University of Cincinnati College of Medicine and Division of Pediatric Infectious Diseases, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati OH"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2025,3,7]]},"reference":[{"issue":"8","key":"2026100510471079200_r1","doi-asserted-by":"crossref","first-page":"168","DOI":"10.15585\/mmwr.mm7308a3","article-title":"Interim estimates of 2023\u201324 seasonal influenza vaccine effectiveness - United States","volume":"73","author":"Frutos","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"2026100510471079200_r2","first-page":"jiae581","article-title":"A phase 1b\/2a single ascending dose study of a half-life extended RSV neutralizing antibody, clesrovimab, in healthy preterm and full-term infants","author":"Madhi","year":"2024","journal-title":"J Infect Dis."},{"key":"2026100510471079200_r3","doi-asserted-by":"crossref","first-page":"115851","DOI":"10.1016\/j.biopha.2023.115851","article-title":"Quantification of clesrovimab, an investigational, half-life extended, anti-respiratory syncytial virus protein F human monoclonal antibody in the nasal epithelial lining fluid of healthy adults","volume":"169","author":"Phuah","year":"2023","journal-title":"Biomed. Pharmacother."}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2024-069926\/1782467\/pediatrics.2024069926.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2024-069926\/1782467\/pediatrics.2024069926.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:47:24Z","timestamp":1791211644000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/155\/4\/e2024069926\/200671\/October-2024-ACIP-Meeting-Update-Influenza-COVID"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,7]]},"references-count":3,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,3,7]]},"published-print":{"date-parts":[[2025,4,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2024-069926","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,7]]},"article-number":"e2024069926"}}